Targeted therapies for high-risk cancer – a reason for hope?
Targeted therapies for high-risk cancers use drugs or substances to specifically attack cancer cells or environments based on their genetic mutations, minimising damage to healthy cells. These therapies may offer a more personalised and effective treatment approach. 

Join us for an insightful session where leading experts will discuss the latest advancements in targeting specific high-risk cancers. This seminar aims to enhance understanding and foster collaboration in cancer research.

Speakers:
Professor Minoti Apte, Professor of Medicine and Director of Research Strategy, South Western Sydney Campus, UNSW Sydney and The Ingham Institute for Applied Medical Research
Professor David Ziegler, Paediatric Oncologist, Kids Cancer Centre; Group Leader for Brain Tumours Group, Children’s Cancer Institute 
Associate Professor Tara Roberts, Oncology Researcher and Lead for Cancer and Inflammation Lab, Western Sydney University and The Ingham Institute for Applied Medical Research.

Session Chair: 
Professor Hubert Hondermarck, Head of the Cancer Neuroscience Laboratory, University of Newcastle  

Related Education & Resources

  • Dr Tiffany Li – Multinational Association of Supportive Care in Cancer | June 2026

    Type of resource:
  • Sharlyn Tan – Multinational Association of Supportive Care in Cancer | June 2026

    Type of resource:
  • Dr Faiqa Mudassar – 22nd International Symposium on Pediatric Neuro-Oncology | June 2026

    Type of resource: